What Is Gastroparesis? Causes, Symptoms, and Treatment

Gastroparesis is a chronic condition in which the stomach takes far longer than normal to empty its contents into the small intestine, even though there is no physical blockage preventing food from moving through. A large U.S. epidemiological study involving over 82 million patients found that type 2 diabetes was the most common underlying cause, accounting for about half of all cases, followed by post-surgical effects, medication-induced slowing, and idiopathic (unknown) causes.¹ The condition is more than just an uncomfortable stomach. It can lead to severe nausea, dangerous weight loss, and a substantially diminished quality of life.

How the Stomach Normally Empties and What Goes Wrong

Your stomach is not a passive bag. Its muscular walls contract in coordinated waves that grind food into tiny particles and push them through the pylorus, the narrow gateway into the small intestine. These contractions are orchestrated by specialized pacemaker cells called interstitial cells of Cajal and by the vagus nerve, which carries signals between the brain and the gut. When either the nerve supply or the pacemaker network is damaged, the rhythmic contractions weaken or become disorganized, and food sits in the stomach far longer than it should.

Pathology studies on patients with severe gastroparesis have found a marked reduction in interstitial cells of Cajal along with thinning and abnormalities in the nerve networks running through the stomach wall.² Manometry research, which measures pressure inside the stomach in real time, has shown that patients with gastroparesis produce significantly fewer and weaker contractions after a meal compared to healthy volunteers. Some patients also develop excessive tightening of the pylorus itself, which acts as a second barrier to emptying.³ In short, the problem can sit at the muscle level, the nerve level, the pacemaker-cell level, or the pylorus, and many patients have a mix of all four.

The Major Causes

Diabetes is the single biggest driver. Long-term high blood sugar damages the autonomic nervous system, including the vagus nerve, progressively eroding the stomach’s ability to contract and empty on schedule.⁴ In the large U.S. dataset, type 2 diabetes accounted for roughly 52% of gastroparesis cases and type 1 diabetes for about 6%.¹ Not everyone with diabetes develops gastroparesis, but the risk climbs as blood-sugar control worsens over years.

Post-surgical gastroparesis is the second most common category, accounting for about 15% of cases in that same dataset. Abdominal operations, especially those near the stomach or esophagus, can injure or sever branches of the vagus nerve.⁵ Fundoplication for reflux, bariatric surgery, and partial gastrectomy are among the procedures most often linked to this complication. Symptoms like nausea, vomiting, and abdominal pain can appear weeks to months after the operation.⁶

Medications are the third leading cause, responsible for about 12% of cases. Opioids, cannabis, anticholinergic drugs, and GLP-1 receptor agonists (the class that includes semaglutide, known by brand names like Ozempic and Wegovy) can all slow gastric emptying substantially.¹ Proton pump inhibitors and anti-Parkinson’s medications have also been flagged.⁷ With the rapid rise of GLP-1 drugs for weight loss and diabetes, medication-induced gastroparesis is getting more clinical attention than it used to. The slowed motility from these drugs can also interfere with the absorption of other medications a person is already taking.⁸

About 11% of cases are classified as idiopathic, meaning no identifiable cause is found despite thorough testing. A small subset of these are suspected to follow a viral illness. In one retrospective review, seven young, previously healthy patients developed persistent nausea, vomiting, and confirmed delayed emptying an average of four and a half days after a viral syndrome resolved. Encouragingly, five of the seven recovered completely over the next few years, and the other two improved considerably.⁹ More recent case reports have documented a similar pattern, with patients going from zero gut symptoms to months of intractable nausea and vomiting in the wake of a viral illness.¹⁰

Recognizing the Symptoms

The hallmark symptoms cluster around what you would expect when food lingers in the stomach too long. Clinicians use a validated scoring tool called the Gastroparesis Cardinal Symptom Index, which tracks three main groups of symptoms: nausea and vomiting, postprandial fullness and early satiety (feeling stuffed after just a few bites), and bloating.¹¹ Upper abdominal pain is also frequently reported and is tracked in newer daily-diary versions of the index.¹²

In studies comparing patients who had confirmed delayed emptying with those whose emptying turned out to be normal, nausea and vomiting scores were significantly higher in the gastroparesis group, along with the inability to finish a normal-sized meal.¹³ However, symptoms alone are not enough to make the diagnosis. There is a large overlap between gastroparesis and functional dyspepsia (a condition with similar symptoms but normal emptying rates), which is why objective testing matters.¹⁴

How Gastroparesis Is Diagnosed

The first step is almost always an upper endoscopy, where a camera is passed down the throat to look inside the stomach. This is not to diagnose gastroparesis directly but to rule out mechanical obstructions like ulcers, strictures, or tumors that could mimic the same symptoms.¹⁵ Gastroparesis is defined by delayed emptying without a physical blockage, so you have to confirm there is no blockage first.¹⁶

Once a structural cause has been ruled out, the gold standard for measuring emptying speed is gastric emptying scintigraphy. You eat a standardized meal (often scrambled eggs mixed with a small amount of a radioactive tracer), and a scanner tracks how quickly the meal leaves your stomach over four hours. Retention of more than 10% of the meal at the four-hour mark is the widely accepted threshold for delayed emptying.

Alternatives exist. A wireless motility capsule, which you swallow like a large pill, measures pressure, pH, and temperature as it travels through the gut. One validation study found that this capsule actually detected delayed emptying in a higher proportion of patients than scintigraphy (about 35% versus 25%), though the two methods agreed roughly three-quarters of the time.¹⁷ A breath test using a meal labeled with a carbon-13 tracer (spirulina platensis) received FDA approval in 2016 and offers a radiation-free alternative that can be performed in an office setting.¹⁸

Who Gets Gastroparesis

Gastroparesis is relatively uncommon in the general population, but far from rare among people with diabetes. Population data from the U.S. have estimated an annual incidence of about 10 per 100,000 in women and roughly 2.4 per 100,000 in men, and the incidence and prevalence in women are about four times higher than in men.¹⁹ That female predominance holds across virtually every subgroup: among people with type 1 diabetes, type 2 diabetes, and idiopathic gastroparesis, women make up roughly 60–66% of cases.²⁰ The reasons are not fully settled, but sex hormones, particularly estrogen and progesterone, appear to influence gastric motility, and differences in nitric oxide signaling in the stomach have been proposed as one biological explanation.²¹

Dietary Changes as a First Line of Defense

Because the stomach struggles to process large volumes and certain food types, adjusting what and how you eat is one of the first practical interventions. The standard dietary advice centers on eating smaller, more frequent meals made up of small-particle, low-fat, and low-fiber foods. Fat slows gastric emptying in healthy people, and fiber can form hard-to-digest masses in a sluggish stomach. That said, recent research has shown that some low-viscosity soluble fibers and fat consumed in liquid form can actually be tolerated well, so the old blanket rules are getting more nuanced.²²

Liquids generally empty from the stomach faster and more reliably than solids, which is why nutritional shakes and blended foods are staples of gastroparesis meal planning. In severe cases where oral intake is not enough to maintain nutrition, a jejunostomy tube that delivers liquid nutrition directly past the stomach into the small intestine may be necessary.

Medications for Gastroparesis

The first pharmacological step, when a medication is causing or worsening the problem, is to stop that medication. Opioids, cannabis, anticholinergics, and GLP-1 agonists are the most common culprits.¹ For patients with diabetes, tightening blood-sugar control is a foundational treatment because acute hyperglycemia itself slows gastric emptying, creating a vicious cycle.

Beyond those baseline measures, medications fall into two broad camps: prokinetics that aim to speed up stomach contractions, and symptom-targeted drugs that focus on nausea, vomiting, and pain even if they do not change how fast the stomach empties.

Among prokinetics, metoclopramide is the most widely prescribed. It works by blocking dopamine receptors in the gut, which promotes contractions, and it also has anti-nausea effects in the brain. However, long-term use carries a risk of tardive dyskinesia, a movement disorder, so the FDA limits its recommended use to 12 weeks. Domperidone is a similar drug used extensively outside the United States but is not FDA-approved; it has a better neurological safety profile because it does not cross into the brain as easily, though it carries a small risk of cardiac rhythm problems. A systematic comparison of prokinetics found that erythromycin, an antibiotic that happens to stimulate the stomach’s motility receptors, had the strongest effect on gastric emptying and the best symptom improvement, though its usefulness tends to fade after a few weeks as the body develops tolerance.²³ Newer prokinetics like prucalopride and itopride work through different receptor pathways and are being studied as alternatives with fewer side effects.²⁴

On the symptom management side, anti-nausea drugs like ondansetron and granisetron are used, though evidence supporting them in gastroparesis specifically comes mostly from case reports and small series rather than large trials.²⁵ Neuromodulators, especially tricyclic antidepressants and mirtazapine, have attracted interest because they can dial down the heightened pain and nausea signaling that some gastroparesis patients experience. Mirtazapine in particular has shown promise in case reports for post-infectious gastroparesis.¹⁰ However, one placebo-controlled trial of the tricyclic nortriptyline in idiopathic gastroparesis found no benefit over placebo, which has raised questions about how broadly useful this strategy is.²⁵ Opioid painkillers, tempting as they might be for severe abdominal pain, are actively discouraged because they worsen nausea and further slow emptying.

When Medications Are Not Enough

For patients whose symptoms remain debilitating despite dietary changes and medication trials, two procedural options have gained traction over the past decade.

Gastric electrical stimulation (GES) involves surgically implanting a small device that delivers mild electrical pulses to the stomach wall. It does not appear to significantly speed up emptying in most studies, but it does seem to reduce nausea and vomiting through pathways that are still not fully understood, possibly by modulating signals sent from the stomach to the brain.

Gastric peroral endoscopic pyloromyotomy (G-POEM) is a newer, less invasive approach. Using an endoscope passed through the mouth, a physician cuts the pyloric muscle from the inside to widen the stomach’s outlet. A propensity-matched comparison of the two approaches found that G-POEM had a significantly longer-lasting clinical response than GES, with an estimated 24-month response rate of about 77% for G-POEM versus 54% for GES. Adverse events were also less common with G-POEM.²⁶ A separate observational study comparing the two treatments for patients with predominant nausea and vomiting found that both produced significant symptom improvement at two years, with roughly 62% responding to GES and 70% to G-POEM, though the difference between the two was not statistically significant in that cohort.²⁷

As a true last resort, partial or complete removal of the stomach (gastrectomy) can be considered, but outcomes for idiopathic and diabetic gastroparesis have generally been disappointing, and the procedure carries significant risks. Gastrectomy tends to be reserved for selected patients with post-surgical gastroparesis who have failed everything else.²⁸

Complications Worth Knowing About

Beyond the daily burden of nausea and poor nutrition, gastroparesis can produce a few specific complications. One is bezoar formation: undigested food, particularly plant fiber, can accumulate into a hard mass in the stomach. In patients with diabetic gastroparesis, poor pyloric function and reduced stomach acid production make this more likely, and a large bezoar can cause a mechanical obstruction on top of the motility problem that was already present.²⁹ Most bezoars can be broken up endoscopically, but they tend to recur if the underlying gastroparesis is not better managed.

For people with diabetes, gastroparesis creates a frustrating feedback loop with blood-sugar management. When the stomach empties unpredictably, the timing of nutrient absorption becomes unpredictable too, which makes it extremely difficult to match insulin doses to meals. Glucose levels swing from too high to too low, which in turn worsens the nerve damage driving the gastroparesis in the first place.

Severe gastroparesis also carries risks of dehydration, electrolyte imbalances, and malnutrition, particularly when vomiting is frequent and oral intake drops below what the body needs to sustain itself.

The Psychological Toll

Living with gastroparesis affects far more than digestion. A systematic review looking at psychological factors across multiple studies found that about a quarter of gastroparesis patients had combined anxiety and depression, and half met criteria for somatization, a pattern of experiencing physical distress linked to psychological factors. Quality of life scores in gastroparesis patients consistently fell below population norms, and worse symptoms tracked with worse psychological outcomes.³⁰ Separate research using the SF-36 quality of life survey confirmed decreased quality of life across the gastroparesis population.³¹

This matters practically because the relationship runs both ways: anxiety and depression can amplify pain perception and nausea, potentially making the gastroparesis feel worse than the degree of delayed emptying alone would explain. It also means that treating the psychological dimension, whether through therapy, medication, or both, can sometimes improve how much the gut symptoms bother a person even before the stomach itself works any differently. Tricyclic antidepressants and mirtazapine, already mentioned as neuromodulators for gut symptoms, can serve double duty in patients who also have significant anxiety or depression.²⁴

The Overlap With Functional Dyspepsia

One of the more confusing corners of this field is where gastroparesis ends and functional dyspepsia begins. Both produce nearly identical symptoms: early satiety, bloating, nausea, upper abdominal discomfort. The main clinical distinction is whether a gastric emptying test comes back abnormal (gastroparesis) or normal (functional dyspepsia). But that line is blurrier than it looks. Emptying speed can fluctuate from day to day, and some patients cross back and forth between delayed and normal on repeat testing.¹⁴ Many of the same treatments, from dietary modifications to prokinetics to neuromodulators, are used for both conditions, which has led some researchers to argue that they may sit on a spectrum rather than being truly separate diseases. For patients, the practical upshot is that a normal emptying test does not necessarily mean your symptoms are imaginary or untreatable. It may simply mean that the standard test did not capture the dysfunction happening in your stomach on that particular day.